Patientsʼ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection
Author:
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population
2. Diagnosis, management, and treatment of hepatitis C
3. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
4. Rate and predictors of treatment prescription for hepatitis C
5. Predictors of treatment in patients with chronic hepatitis C infection-Role of patient versus nonpatient factors
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases;Kidney Medicine;2022-04
2. Tolerance and acceptance for unsedated diagnostic upper gastrointestinal endoscopy in Kaduna, North-West Nigeria;Nigerian Postgraduate Medical Journal;2022
3. Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections;Advances in Therapy;2019-06-25
4. Direct-acting antiviral treatment for HIV/HCV patients in safety net settings: patient and provider preferences;AIDS Care;2019-03-04
5. Drugs Cleared Through The FDA’s Expedited Review Offer Greater Gains Than Drugs Approved By Conventional Process;Health Affairs;2017-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3